Ventilator-Associated Pneumonia (VAP) Market: Emerging Trends Shaping Critical Care Infection Management
The Ventilator-associated pneumonia (VAP) market is on the verge of remarkable growth, characterized by a projected market size of $1,957.74 million in 2024 and an astounding $3,137.49 million by 2035. This represents a compound annual growth rate (CAGR) of 10.2%. Such figures underscore the growing urgency for innovative solutions in infection control, specifically targeting VAP, a condition...
0 Commenti 0 condivisioni 149 Views 0 Anteprima